Varisacumab (Anti-VEGFA)

Varisacumab (Anti-VEGFA) is a human recombinant monoclonal antibody targeting VEGFA. It may be used in research of Microvascular complications of diabetes 1 (MVCD1). MW :145.62 KD.
Supplier Selleck Chemicals
Product # A3108
Sku # A3108-1mg*25
Pricing 1mg*25, $5070.00
Feedback